Odyssey Therapeutics Acquires Rahko, a Quantum Machine Learning Company

BOSTON, Jan. 6, 2022 /PRNewswire/ — Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced that it has acquired Rahko, a leading quantum machine learning company, adding powerful new tools to Odyssey’s…